Novo Nordisk: Adjusted sales of DKK 78.49 billion for the second quarter of 2026; adjusted operating profit of DKK 33.39 billion.

Zhitongcaijing · 1d ago
Novo Nordisk: Adjusted sales of DKK 78.49 billion for the second quarter of 2026; adjusted operating profit of DKK 33.39 billion.